Millendo Therapeutics, Inc.
Millendo Therapeutics, Inc. (MLND) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 8 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Dec 7, 2018 involved a transaction of 755 shares valued at $0.
MLND Insider Activity Summary
Who Is Buying MLND Stock?
No significant insider buying has been recorded for MLND in the recent period.
Who Is Selling MLND Stock?
No significant insider selling has been recorded for MLND in the recent period.
Is Millendo Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MLND is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
MLND Frequently Asked Questions
Understanding MLND Insider Activity
Insider trading at Millendo Therapeutics, Inc. (MLND) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading MLND stock, having executed 8 transactions in the past 90 days. The most active insider is Richard Aldrich (Executive), who has made 1 transactions totaling $0.
Related Tools
Track Millendo Therapeutics, Inc. Insider Activity
Get notified when executives and directors at MLND file new Form 4 transactions